OPTIC Key Takeaways
Key Takeaways are OPTIC-created, one-page summaries of published research findings tailored for policymakers.
Note: the links below will directly download a PDF file of the indicated Key Takeaway. If you prefer to view the document in a new browser tab:
- PC users - right click on the Key Takeaway link and choose "Open link in new tab"
- Mac users - Press and hold the control key while clicking on the Key Takeaway link and choose "Open link in new tab"
- Access to Office-Based Buprenorphine Treatment in Areas With High Rates of Opioid-Related Mortality
- Details of Naloxone Access Laws Make a Difference
- Do Policies Related to Substance Use in Pregnancy Affect Rates of Neonatal Abstinence Syndrome?
- Examining Access to Buprenorphine-Waivered Prescribers in U.S. Counties
- Greater Prevalence of Illicit Opioids Reduces Labor Supply and Increases Claims for Disability Insurance
- Has Expanded Access to Buprenorphine Expanded Treatment for Medicaid Enrollees?
- High-Risk Prescribing to Medicaid Enrollees Receiving Opioids for Pain Relief
- How Pregnancy and Insurance Status Affect Access to Treatment for Opioid Use Disorder
- How Prescription Drug Monitoring Programs Affect Opioid Utilization Among Medicare Beneficiaries
- Increase Access to Buprenorphine by Supporting the Most Active Prescribers
- The Cascading Effects of the Reformulation of OxyContin
- The Social Context of Neonatal Abstinence Syndrome
- Increasing Access to Buprenorphine for Treating Opioid Use Disorder
- Who Receives Naloxone from Emergency Medical Services?